Atlanticus Holdings Corp
A financially robust North American holding company driving growth through specialty chemicals and industrial distribution while maintaining a healthy cash position.
A financially robust North American holding company driving growth through specialty chemicals and industrial distribution while maintaining a healthy cash position.
Investors may buy ATLC because its strong operating cash flow and growing revenue trend suggest sustainable profitability, while the company's aggressive share repurchase program signals confidence in future prospects. The diversified business model provides a defensive quality that can weather economic fluctuations, and the substantial cash pile offers flexibility for strategic M&A or further capital returns to shareholders.
Potential concerns include the company's high debt load relative to its asset base, which creates interest expense pressure of over $160M that could erode margins in a rising rate environment. The significant cash outflow from investing activities indicates heavy capex or acquisitions that may not yet be yielding sufficient returns, and reliance on cyclical industries exposes the stock to commodity price volatility and demand shocks.
Atlanticus Holdings Corp (ATLC) is a diversified holding company operating primarily in North America and Europe, focusing on specialty chemicals, industrial distribution, and strategic investments. The company leverages its extensive network of manufacturing facilities and logistics capabilities to serve automotive, aerospace, and energy sectors with high-value materials and engineered components. With a strong balance sheet and consistent profitability, ATLC aims to capitalize on global supply chain modernization and emerging market opportunities.
Atlanticus delivered solid financial performance in 2024 with revenue reaching $1.31B and net income of $110.1M, demonstrating resilience despite a challenging macro environment. The company generated robust operating cash flow of $469.4M, allowing it to fund $52.7M in share repurchases while managing substantial debt repayments of $566.2M, resulting in a net increase in cash holdings from $375.4M to $499.6M.
The specialty chemicals and industrial distribution industry is characterized by high barriers to entry due to complex regulatory requirements and established customer relationships. While consolidation is accelerating as smaller players struggle with margin compression, successful firms like Atlanticus that control supply chains and offer integrated solutions are well-positioned for long-term growth.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $1.05B | $1.16B | $1.31B |
| Cost of Revenue | $95.4M | $100.6M | $118.4M |
| Gross Profit | $951.5M | $1.06B | $1.19B |
| Operating Expenses | $802.2M | $926.7M | $1.05B |
| Operating Income | $149.3M | $128.6M | $138.6M |
| Stock-Based Comp | $4.2M | $3.8M | $3.9M |
| Depreciation | $2.2M | $2.6M | $2.7M |
| Non-Operating Income | $0 | $0 | $0 |
| Interest Expense | $81.9M | $109.3M | $160.2M |
| Pre-Tax Income | $149.3M | $128.6M | $138.6M |
| Income Tax | $14.7M | $26.6M | $28.5M |
| Continuing Ops | $134.6M | $102.0M | $110.1M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $134.6M | $102.0M | $110.1M |
| Minority Interest | $-985.0K | $-891.0K | $-1.2M |
| Net to Common | $135.6M | $102.8M | $111.3M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Cash & Equivalents | — | — | $375.4M |
| PP&E (Net) | $10.0M | $11.4M | $10.5M |
| Operating Leases | $11.8M | $11.3M | $13.9M |
| Total Assets | $2.39B | $2.71B | $3.27B |
| Total Liabilities | $1.92B | $2.17B | $2.69B |
| Shareholders' Equity | $465.0M | $532.7M | $579.4M |
| Retained Earnings | $204.4M | $307.3M | $394.6M |
| Total L&E | $2.39B | $2.71B | $3.27B |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $134.6M | $102.0M | $110.1M |
| Non-Cash Adjustments | $-57.5M | $107.5M | $88.0M |
| Working Capital Changes | $269.0M | $249.9M | $271.3M |
| Cash from Operations | $346.1M | $459.3M | $469.4M |
| Cash from Investing | $-680.8M | $-672.2M | $-747.0M |
| Debt Repayments | $309.8M | $753.9M | $566.2M |
| Share Buybacks | $89.0M | $17.7M | $52.7M |
| Cash from Financing | $261.3M | $163.3M | $393.6M |
| FX Effect | $-36.0K | $2.0K | $0 |
| Net Change in Cash | $-73.4M | $-49.5M | $116.0M |
| Beginning Cash | $506.6M | $433.2M | $383.7M |
| Ending Cash | $433.2M | $383.7M | $499.6M |
The company's revenue is derived from three primary streams: 1) Specialty Chemicals Manufacturing, generating significant gross profit margins on high-value formulations; 2) Industrial Distribution and Logistics, providing supply chain solutions for key industries like automotive and aerospace; and 3) Strategic Investment Holdings, utilizing its substantial cash reserves to acquire undervalued assets or minority stakes in complementary businesses.
Major risks include significant debt repayment obligations totaling over $566M which could strain liquidity if earnings decline, exposure to volatile raw material costs impacting gross margins, sensitivity to global economic downturns affecting demand in automotive and energy sectors, and potential regulatory changes in chemical manufacturing and environmental compliance.
Atlanticus possesses deep domain expertise in niche chemical formulations that create high switching costs for enterprise clients, a resilient distributed logistics network that mitigates supply chain shocks, and a disciplined capital allocation strategy evidenced by strong operating cash flow relative to net income.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.